Cellectis (CLLS) Change in Intangibles (2015 - 2025)
Cellectis (CLLS) posted quarterly Change in Intangibles of -$1.2 million for Q3 2025, down 4050.0% year-over-year from $29417.7 in Q3 2024, and down 4050.0% quarter-over-quarter from -$28000.0 in Q3 2024.
Powered by 
Analysis
Cellectis (CLLS) Change in Intangibles (2015 - 2025) Analysis & Trends
Cellectis' Change in Intangibles history runs 10 years deep, the most recent figure standing at -$1.2 million for Q3 2025.
- In Q3 2025, Change in Intangibles fell 4050.0% year-over-year to -$1.2 million; the TTM figure through Sep 2025 stood at -$1.2 million (down 438.16% YoY), while the FY2016 annual figure was -$337652.6, down 249.4% from the prior year.
- Change in Intangibles for Q3 2025 stood at -$1.2 million, down from -$28000.0 in the prior quarter.
- The five-year high for Change in Intangibles was -$1000.0 in Q2 2021, with the low at -$1.2 million in Q3 2025.
- The 4-year median for Change in Intangibles is -$37000.0 (2024), against an average of -$324285.7.
- The sharpest annual moves came in 2021 and 2022: Change in Intangibles plunged 42750.0% in 2021, then surged 80.98% in 2022.
- Cellectis' Change in Intangibles stood at -$857000.0 in 2021, then soared by 80.98% to -$163000.0 in 2022, then surged by 82.82% to -$28000.0 in 2024, then sank by 4050.0% to -$1.2 million in 2025.
- Business Quant data shows CLLS's Change in Intangibles at -$1.2 million in Q3 2025, -$28000.0 in Q3 2024, and -$37000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -11,000.00 |
| Dec 31, 2024 | -1.20 Mn |
| Sep 30, 2024 | -28,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Dec 31, 2022 | 184,000.00 |
| Sep 30, 2022 | -163,000.00 |
| Dec 31, 2021 | 867,000.00 |
| Sep 30, 2021 | -857,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -22,000.00 |
| Dec 31, 2020 | -304,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | -43,000.00 |
| Dec 31, 2019 | -13,000.00 |
| Sep 30, 2019 | -3,000.00 |
| Jun 30, 2019 | -26,000.00 |
| Mar 31, 2019 | -3,000.00 |
| Dec 31, 2018 | -175,000.00 |
| Sep 30, 2018 | 3,000.00 |